SCHEMBL2178707

SCHEMBL2178707

CNc1nccc(-c2cc(NC(=O)C(N)CCOC(C)C)c3cc(OC)ccc3c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.36
NCOR1 O75376 1/20 0.36
HDAC2 Q92769 1/20 0.36
AAK1 Q2M2I8 3/20 0.35
CIT O14578 3/20 0.35
GPR142 Q7Z601 1/20 0.35
RIOK2 Q9BVS4 4/20 0.35
PIK3CA P42336 3/20 0.34
PIK3CG P48736 2/20 0.34
PIK3CB P42338 1/20 0.34
GSK3A P49840 2/20 0.33
MAPK10 P53779 2/20 0.33
CCNC P24863 2/20 0.33
CDK8 P49336 2/20 0.33
SRC P12931 1/20 0.33
FLT3 P36888 1/20 0.33
ITK Q08881 1/20 0.33
MAPK8 P45983 1/20 0.33
CAMKK2 Q96RR4 1/20 0.33
ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179091 0.93 HDAC3 (0.39) HDAC3NCOR1HDAC2AAK1CIT
SCHEMBL2180455 0.90 HDAC3 (0.36) HDAC3NCOR1HDAC2AAK1CIT
SCHEMBL2178535 0.90 HDAC3 (0.38) HDAC3NCOR1HDAC2CITGPR142
SCHEMBL2178713 0.85 HDAC3 (0.36) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL6128583 0.84 HDAC3 (0.35) HDAC3NCOR1HDAC2RIOK2PIK3CA
SCHEMBL2181038 0.84 ABL1 (0.38) HDAC3NCOR1HDAC2GPR142PIK3CA
SCHEMBL2180584 0.84 HDAC3 (0.36) HDAC3NCOR1HDAC2AAK1CIT
SCHEMBL2178871 0.83 MEN1 (0.37) HDAC3NCOR1HDAC2GPR142PIK3CA
SCHEMBL2679428 0.81 MTNR1A (0.38) HDAC3NCOR1HDAC2PIK3CAPIK3CG
SCHEMBL2178148 0.80 HSD17B1 (0.46) HDAC3NCOR1HDAC2PIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP HDAC3 1641/4885NCOR1 418/4885HDAC2 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.